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NSULIN RESISTANCE is compensated for by increased insulin secretion. 1-3 The mechanism of the islet compensation might involve a slight but continuous hyperglycemia. which stimulates basal insulin secretion and potentiates nonglucose-stimulated insulin secretion, as inferred from studies in humans. 1,2,4 The mechanism might also involve cholinergic hyperactivity, as indicated by studies in the glucose-infused rat. in which the potentiated glucose-stimulated insulin secretion was inhibited by atropine, s and in the insulin-resistant obese mouse, in which atropine reduced hyperinsulinemia. 6 Similarly, the frequency of diabetes induced by low-dose alloxan in mice has been shown to be increased by muscarinic blockade. 7 and the insulin secretory response to muscarlnic activation by bethanechol has been shown to be exaggerated in the obese mouse. 8 Following long-standing insulin resistance, this compensation in islet function might fail. resulting in a decompensated state precipitating non-insulin-dependent diabetes mellitus. However. the islet consequences of long-standing insulin resistance are not established. To increase our understanding of the islet consequences of long-standing insulin resistance, we examined the C57BL/6J strain of mice. the genetic background of which carries a phenotype characterized by a high occurrence of insulin resistance When metabolically challenged. 9,1° It has. for instance, been demonstrated that when C57BL/6J mice are fed a high-fat diet. severe insulin resistance with hyperinsulinemia develops, in contrast to Only a marginal hyperinsulinemia in another strain, the A/J mouse, given the same high-fat diet. 11 Furthermore. 4 months of treatment of C57BL/6J mice with a high-fat diet has been shown to induce hyperglycemia, hyperinsulinemia. Slight obesity, and an impaired insulin secretory response to glucose." 13
In the present study, we frequently examined islet function in C57BL/6J mice during 12 weeks of treatment with a high-fat diet. We studied insulin secretion in vivo and in vitro, and examined islets from C57BL/6J mice using immunocytochemistry and quantitative in situ hybridization for assessment of islet morphology and insulin gene expression. We paid particular attention to a potential difference in the islet response to glucose versus the cholinergic agonisc carbachol, in line with the hypothesis that cholinergic supersensitivity is a mechanism underlying the islet adaptation to an increased requirement for insulin that accompanies insulin resistance. 5-8
MATERIALS AND METHODS

Animals
A total of 264 female mice of the C57BL/6J strain were obtained from Bomholtgaard Breeding and Research Centre (Ry, Denmark) at 4 
Baseline Parameters
At day 4 after arrival, ie, when treatment with the various diets startedl and then once every week for the study period of 12 weeks, all animals and food consumption were weighed, and a blood sample was taken from the intraorbital, retrobulbar plexus for measurement of plasma levels of insulin and glucose.
In Vivo Experiments
After 4, 8, and 12 weeks of treatment with a high-fat/c0ntrol diet, all mice underwent one in vivo study. The animals were injected intraperitoneally with D-glucose (Sigma Chemical, St Louis, MO) at a dose level of 2.8, 8.3, or 16.7 mmol/kg, with the cholinergic agonist carbachol (Sigma) at a dose level of 0.16 or 0.53 gmol/kg or saline. The volume load was 10 taL/g body weight. Blood samples were taken at 6 and 10 minutes after the respective injection; initial exper!ments showed that peak levels of plasma insulin after intraperitoneal injection Of glucose or carbachol in this strain of mice Occurred within this period (data not shown). The samples were immediately centrifuged, and the plasma was stored at -20°C until assayed. The mean plasma levels of glucose, insulin, and glucagon were calculated for the 6-and 10-minute values, and the mean value obtained in the control saline-injected group in the same series was subtracted from the mean 6-to 10-minute value obtained in each experimental animal.
In Vitro Experiments
After 4, 8, and 12 weeks of treatment with a high-fat or control diet, pancreatic islets were isolated from four mice in each batch with a collagenase isolation technique modified from the study by Lacy and Kostianovsky. 14 In brief, the pancreas was retrogradely filled with 3 mL Hanks balanced salt solution (Sigma) supplemented with 0.3 mg/mL Collagenase P (activity, 1.86 U/mg; Boehringer, Mannheim, Germany). The pancreas was subsequently removed and incubated in the same solution for 20 minutes at 37°C. After rinsing, the islets were handpicked under a stereomicroscope and incubated overnight in RPMI 1640 medium supplemented with 10% fetal calf serum, 2.05 mmol/L L-glutamine, 2.5 gg/mL amphotericin B (GIBCO BRL, Paisley, Scotland), 100 IU/mL penicillin, and 100 gg/mL streptomycin (Biol Ind, Beit Haemek, Israel) at 37°C in humidified air equilibrated with 5% CO2. Following overnight incubatio n, the islets were washed three times and then preincubated for 60 minutes at 37°C in a HEPES medium (pH 7.36) supplemented with 0.1% human serum albumin (Sigma) and 3.3 mmol/L glucose. The medium consisted of the following (in mmol/L): 125 NaC1, 5.9 KC1, 1.2 MgC12, 1.28 CaC12 (all Sigma), and 25 HEPES (Boehringer). After the preincubation, groups of three islets were transferred to separate chambers containing 200 pL of the medium supplemented with glucose at various concentrations: Following incubation at 37°C for 60 minutes, 25 pL of the medium was collected from each chamber and stored at -20°C until analysis.
Pancreatic Insulin Extraction
For analysis of pancreatic insulin, approximately 50 mg of the Pancreas was removed from each animal and weighed. The tissue was thereafter homogenized in acid ethanol (0.18 mol/L HC1 in 95% ethanol) followed by radioimmunoassay for insulin.
Analysis of Insulin, Glucagon, and Glucose
Insulin in plasma, medium, and extracted tissue was determined radioimmunochemically is with a guinea pig anti-rat insulin antibody, ~2SI-labeled porcine insulin as tracer, and rat insulin as standard (Linco Research, St Louis, MO). Free and bound radioactivity was separated by use of an anti-IgG (goat anti-guinea pig) antibody (Linco). The sensitivity of the assay is 12 pmol/L, and the coefficient of variation is less than 7% at both low and high levels. Analyses of glucagon concentrations were performed on unextracted plasma 16 with a doubleantibody radioimmunoassay using guinea pig antiglucagon antibodies specific for pancreatic glucagon, 125I-glucagon as tracer, and glucagon standard (Linco). The sensitivity of the assay is 7.5 pg/mL, and the coefficient of variation is less than 9% at both low and high levels. Plasma glucose was determined by the glucose oxidase method. 17
Analysis of Cholesterol, Triglycerides, and Free Fatty Acids
At 6 weeks after the start of treatment with a high-fat or control diet, blood was collected and plasma separated for determination of total cholesterol, triglycerides, and free fatty acids (FFAs). Total cholesterol level was measured enzymatically, 18 and triglycerides and FFAs were determined colorimetrically.W,2°
Immunocytochemistry
After 12 weeks of treatment with a high-fat or control diet, pancreatic specimens were removed and fixed overnight by immersion in Stefanini's solution (2% paraformaldehyde and 1.5% saturated solution of picric acid in 0.1 mol/L phosphate-buffered saline, pH 7.2). After rinsing in sucrose-enriched (10%) buffer, the specimens were frozen on dry ice. Sections were cut at 10 grn thickness in a cryostat and mounted on chromalum-coated slides. The sections were then processed for
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vasoactive intestinal polypeptide (VIP), tyrosine hydroxylase (TH), galanin, and substance P (SP) using the indirect immunofluorescence technique. 21 Details of the antisera are shown in Table 1 . Fluorescein isothiocyanate-labeled porcine antisera against rabbit or guinea pig IgG were used as secondary antisera (dilution 1:80; EuroDiagnostica, Malta6, Sweden). Control sections were incubated with the antisera (in working dilution) preabsorbed with the respective antigen in excess (obtained from Peninsula Europe, Merseyside, England; 10 to 100 lag/mL). The relative frequency of peptide-containing nerve fibers was assessed semiquantitatively by two independent observers. The final score was the mean of these estimations, and was graded as follows: 0, no fibers; 1, occasional nerve fibers; 2, moderate number of nerve fibers; and 3, numerous nerve fibers. At least seven sections were examined for each type of nerve fiber (NPY, VIR TH, galanin, and SR respectively).
In Situ Hybridization
Insulin mRNA was detected in situ in islets using a mix of oligonucleotide probes complementary to rat insulin mRNA I and II (BPR 236; R&D Systems, Abingdon, Oxon, UK); the probes were 3'-end-tailed with 35S as previously described. 22 The protocol for in situ hybridization has previously been described in detail. 22 Briefly, the pancreatic sections (5 bun thickness) were deparaffmized, rehydrated, and permeabilized in 0.01% Triton X-100. Before hybridization, the sections were treated with proteinase K (10 lag/mL; Sigma) and acetylated by 0.25% acetic anhydride in 0.1 mol/L triethanolamine. Hybridization was performed overnight at 37°C in sealed moisturizing chambers, using a probe concentration of 200 fmol/mL. Following stringent posthybridization washing, the slides were dipped in Ilford K-5 emulsion (Ilford Anitec, G6teborg, Sweden), exposed for 7 days, and developed in Kodak D-19 (Kodak, Stockholm, Sweden). Levels of insulin mRNA were determined by quantification of probe labeling of islets, using Q 500 MC Leica (Leica Cambridge, Cambridge, UK) as previously described in detail. 23 Briefly, before analysis, the system was calibrated by conversion of the grey values in a standard section to optical density (OD), yielding an arbitrary scale from 0 to 5. The calibration and illumination of the sections in the microscope were checked repeatedly during analysis to ensure that mRNA levels were determined under identical conditions. Dark-field images of islets were captured and digitized, and the polarity was reversed. The outline of the islets was interactively defined by the investigator. Subsequently, the NOTE. Values are the mean ± SEM for the 6-and 10-minute plasma samples. Carbachol was injected at either of 2 dose levels, and samples were taken 6 and 10 minutes after injection. Number of animals is in parentheses.
mean OD within the islets was determined, correlating with the amount of probe hybridized to an islet and thus to the insulin mRNA abundancy. In addition, the total area of insulin probe-labeled cells in the islets was determined, thereby yielding data on B-cell mass. Sections from each individual animal were analyzed in duplicate; 10 randomly selected islets from different parts of the sections were analyzed.
Statistics
The mean ± SEM are reported. Statistical comparisons for differences between mice treated with a high-fat or control diet in body weight, food intake, and baseline plasma levels of insulin, glucose, and lipids were performed by Student's t test. Differences with regard to insulin, glucagon, or glucose responses to glucose or carbachol in vivo or to insulin secretion in vitro were evaluated by two-way ANOVA and the Newman-Keul post hoc test. Insulin mRNA levels, areas of insulin probe-labeled cells, insulin cell numbers, and the relative frequency of NPY and VIP nerves were compared using a two-tailed Mann-Whitney U test.
RESULTS
Body Weight
Already after 1 week of treatment with the high-fat diet, body weight was significantly higher compared with control levels (18.0 _+ 0.1 v 16.8 _+ 0.1 g, P < .001; Fig 1) . After 12 weeks, body weight in mice given the high-fat diet was 25.8 _+ 0.4 g (n = 109), versus 21.3 + 0.2 g in controls (n = 91, P < .001).
Food Intake
Daily food intake was stable in the two groups of mice throughout the study (Fig 2) . Daily energy intake was slightly but significantly higher in mice given the high-fat diet than in controls (Fig 2; P < .01 between groups at all time points).
Baseline Glucose and Insulin
After 1 week on the high-fat diet, hyperinsulinemia was seen that persisted throughout the study period (Fig 3) . After 12 weeks of treatment, plasma insulin levels in mice given the high-fat diet were 248 _+ 17 pmol/L (n = 109), versus 104 _+ 7 pmol/L in control mice (n = 91, P < .001). Also, plasma glucose levels were increased after 1 week of treatment with the high-fat diet; this difference of approximately 1 mmol/L was present throughout the study period. After 12 weeks, plasma glucose levels in mice given the high-fat diet were 7.5 _+ 0.1 mmol/L (n = 109), versus 6.5 -+ 0.1 mmol/L in controls (n = 91, P < .001; Fig 3) .
Plasma Lipids
After 6 weeks of treatment with the high-fat diet, plasma levels of cholesterol, triglycerides, and FFAs were all significandy elevated compared with levels in mice given the control diet (Fig 4) .
Glucose-Stimulated Insulin Secretion In Vivo
At 4 and 8 weeks after starting the high-fat or control diet, glucose-stimulated insulin secretion was not different between the two groups of animals (Fig 5) . However, after 12 weeks of treatment, the plasma insulin response to glucose injected at 16.7 mmol/kg was impaired after the high-fat diet, since it was 446 -+ 56 pmol/L in control animals (n = 14), versus only 203 + 62 pmol/L in animals given the high-fat diet (n = 15, P = .008; Fig 5) .
Carbachol-Stimulated Insulin and Glucagon Secretion In Vivo
After 4 weeks of treatment with the two diets, there was no significant difference between the two groups with regard to carbachol-stimulated insulin secretion (Fig 6) . However, after both 8 and 12 weeks of treatment, carbachol-stimulated insulin secretion was exaggerated in mice given the high-fat diet compared with the control diet (Fig 6) . Thus, after 12 weeks of treatment, carbachol at 0.53 ~tmol/kg increased plasma insulin by 3,105 -+ 308 pmol/L in mice given the high-fat diet, versus an increase of only 1,544 _+ 256 pmol/L in controls (P = .002). In contrast, carbachol-stimulated glucagon secretion did not differ significantly between the two groups at any of the studied time points (Table 2) .
Glucose-Stimulated Insulin Secretion In Vitro
After 4 and 8 weeks of treatment, no significant difference was evident between the two groups regarding glucosestimulated insulin secretion in vitro (Fig 7) . However, after 12 weeks of treatment, glucose-stimulated insulin secretion was markedly impaired in mice given the high-fat diet, since the medium insulin concentration was lower after incubation of islets from these animals at glucose concentrations of 8.3 mmol/L (P = .038), 11.1 mmollL (P = .021), and 16.7 mmol/L (P < .001).
Cellular Expression of Insulin
No visible difference was observed between the two groups of mice with regard to insulin-like immunofluorescence, as illustrated in representative islets from mice given the control or high-fat diet for 12 weeks (Fig 8) . Similarly, pancreatic insulin content after 12 weeks of treatment did not differ between the groups (4.0 _+ 1.1 pmol/mg wet weight in pancreas from high-fat diet-treated mice, n = 6, v 3.9 _+ 0.8 in controls, n = 6, NS). Figure 9 illustrates representative in situ hybridizations of islets from the two groups of mice, hybridized with oligonucleotides complementary to proinsulin mRNA. Insulin gene expression was markedly increased after the high-fat diet. Quantitative in situ hybridization showed that insulin probe labeling was increased approximately 3.5-fold in mice given the high-fat diet for 12 weeks compared with the controls (Fig 10; P < .001) . In contrast, B-cell mass, as shown by the total area of the insulin probe-labeled cells, was not different between the groups: 14,516 + 1,862 gm 2 in mice given the high-fat diet (n = 61 islets from nine animals) compared with 14,656 _+ 1,653 gm 2 in controls (n = 60 islets from eight animals, NS).
Insulin Gene Expression
Neural Expression of lslet Neuropeptides
Pancreatic tissues from control and high-fat diet-treated mice were immunostained for markers of islet nerves. Figure 11 shows representative islet immunostaining in the two groups of mice for two different neuropeptides: NPY, a marker for pancreatic adrenergic nerves, and VIP, a marker for pancreatic parasympathetic, presumably cholinergic, nerves. 24 In both groups of mice, islet innervation with nerves harboring these two neuropeptides was evident. However, there was no difference in the relative frequency of innervati°n with NPY and VIP fibers between the two groups of mice (Fig 12) . Furthermore, in both groups of mice, islet innervation with nerves immunoreactive for TH and galanin (neuropeptide in pancreatic adrenergic nerves 24) and SP (marker for sensory nerves 25) was evident. However, similarly as for NPY and VIE there was no difference in the relative frequency of TH, galanin, and SP fibers between the two groups.
D I S C U S S I O N
In this study, we confirm previous reports by Surwit et a111,12 that a high-fat diet increases body weight and induces insulin resistance in mice of the C57BL/6J strain, as evident by slight hyperglycemia and marked hyperinsulinemia already after 1 week. We also found that this insulin resistance was accompanied later (12 weeks) by impaired glucose-stimulated insulin secretion, which enforces the idea that this strain of mice carries a genetic predisposition to develop type II diabetes mellitus. 11 We focused our interest on the first 12 weeks of treatment with a high-fat diet to establish the consequences for the islet adaptation of reduced insulin resistance after several weeks, but before diabetes evolves.
Reduced insulin sensitivity is compensated for by hyperinsulinemia to avoid hyperglycemia. 1-3 Previous studies in the glucose-infused rat and the ob/ob mouse have suggested that increased sensitivity to cholinergic activation might be a mechanism underlying the compensatory hyperinsulinemia. 5 8 Thus, in the ob/ob mouse, muscarinic blockade by atropine reduces plasma insulin levels, 6 and similarly, ob/ob mice exhibit an increased insulinotropic action of the muscarinic agonist bethanechol. 8 Cholinergic activation by means of vagal nerve activation or administration of muscarinic agonists is known to stimulate insulin secretion .8,26-28 Increased vagal activity or muscarinic sensitivity as a compensatory response to peripheral insulin resistance would therefore increase insulin secretion. We examined this by Challenging the mice with the ch91inergic agonist carbachol at 4, 8, and 12 weeks after the start of a high-fat diet. We found an increased insulinotropic respons e to the cholinergic agonist carbachol after 8 weeks of treatment with the high-fat diet. This result suggests that increased muscarinic activity develops as a compensation for insulin resistance. Increased B-cell ch01inergic •sensitivity might therefore be of importance for maintenance of long-term hyperinsulinemia. Vagal nerve activation and muscarinic agonism also stimulate glucagon secretion. 28,29 However, in contrast to the potentiated insulinotropic action of carbachol in high-fat diettreated mice, the glucagon0troplc effect of carbachol was found not to be augmented after treatment with a high-fat diet. This shows that the increased sensitivity to muscarinic activation is restricted to insulin secretion, rather than being an unspecific hyperactivity in the vagal system.
In contrast to the exaggerated insulinotropic response tO cholinergic stimtdation, C57BL/6J mice given a hlgh-fat diet developed impaired glucose-stimulated insulin sec/etion under both in vivo and in vitro condit!ons after 12 weeks of treatment. This shows that tlae marke d hyperinsulinemia at this stage is not dependent on a potentiated insulinotropic response to glucose. Further, the hyperinsulinemia is not caused by islet hypertrophy, since B-cell mass was not altered by the high-fat diet Moreover, mite given the high-fat diet ha d increased insulin mRNA leve!s despite the •unaffected B-cell mass and Pancreatic insulin content. This indicates that the insulin biosynthetic machinery is highly activated in insulin resistance and that insulin turnover is increased, causing increased insulin release. Thus, it seems that long-stancfing insulin resistance for 8 to 12 weeks induces increased insulin gen e expression and increased B-cell sensitivity to cholinergic activation together with impairment of gluc0se-stimulated insulin secretion. We found that following long'term insulin resistance of 12 weeks, the insulin secretory response to glucose failed. This phenomenon may represent an early decompensation in islet function that might be a mechanism of importance i n diabetes path0genesis. Several explanations may be offered for the failing glucose-stimulated insulin secretion following treatment with a high-fat diet for several weeks. One possible explanation is increased sympathoadrenal activity, which has been demonstrated in C57BL/6J mice given a high-fat diet showing increased glycemic responses to slress and epinephrine. 11,12 Such a n increased sympathoadrenal activation would diminish insulin secretionY Another explanation is that the hyperglycemia, although slight but chronic, impairs islet function due to a long-standing B-cell glucose toxicity. 3°,31 However, this expla: nation is unlikely in these mice, since it previously has been demonstrated that a 7-day exposure to high glucose (28 and 56 mmo1/L) did not cause any deterioration in islets isolated from C57BL/6J mice. 32 A third explanation is that the hyperlipidemia, particularly the increased circulating levels of triglycerides and FFAs, that were evident in our mice, caused the deteriorated glucose-stimulated insulin secretion. In fact, it has previously been demonstrated that lipid infusion in rats inhibits glucose-stimulated insulin secretion) 3 and several groups have shown that islets incubated during a long period with fatty acids exhibit inhibited glucose-stimulated insulin secretion. 34-36 However, in the present study, this explanation was not explored in detail, since plasma lipid levels were determined only after 6 weeks on the high-fat diet. Finally, a fourth explanation is that a high-fat diet induced impaired signaling mechanisms crucial to insulin secretion, in analogy with recent findings in the Zucker diabetic fattY rat. 37 However, the exact nature of the mechanism of the impaired glucose-stimulated insulin secretion in C57BL/6J mice on a high:fat diet remains m be clarified. It should be emphasized that we found the impaired insulin secretion under both in vitro and in vivo conditions, which indicates that long-term alterations of islet function rather than in vivo conditions determine the failing insulinotropic action of glucose.
As demonstrated by our immunocytochemical analysis of the islets, the pattern of islet innervation was not altered by a high-fat diet. We studied the innervation pattern of islets with regard to TH. NPY, and galanin, which are associated with sympathetic adrenergic nerves, with VIR which is associated with parasympathetic cholinergic nerves, and with SR which is associated with sensory nervesY ,25 However. all these different fibers in the islets disp!ayed a similar distribution pattern and relative frequency in mice given the high-fat and control diets. This suggests that changes in insulin secretion after treatment with the high-fat diet are not related to an altered pattern of innervation from a morphologic point of view. which does not exclude functional alterations in the neural regulation of islet hormone secretion.
In conclusion, we have demonstrated that treatment of the C57BL/6J strain of mice with a high-fat diet induces insulin resistance already after 1 week. as shown by marked hyperinsu|inemia and slight hyperglycemia. Furthermore. after 12 weeks of treatment, glucose-induced insulin secretion is impaired both in VlVO and in vitro, whereas carbachol-stimulated insulin secretion is potentiated. Moreover. the insulin gene is upregulated, but the islet size is not altered. Based on these results, we suggest that cholinergic supersensitivity and an increased B-cell turnover of insulin is a mechanism compensating for the peripheral insulin resistance with increased insulin secretion. whereas the falling glucose-stimulated insulin secretion represents an early decompensation in islet function.
